Jakub Trefler

6PUBLICATIONS
16CO-AUTHORS
Rheumatology and arthritisAllergyPharmaceutical delivery technologiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Complement C3c Reflects Acute-Phase Response but Not Clinical Phenotype in Systemic Sclerosis: A Cross-Sectional Study.

|Dec 02, 2025
Lower total serum Immunoglobulin G is associated with impaired patient-reported health-related quality of life in systemic sclerosis: a prospective cross-sectional study.

Jakub Trefler, Anna Pasierb, Lidia Lech

|Jul 12, 2025
Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.

Mark G Lebwohl, John Y Koo, Janusz Jaworski

|Mar 28, 2025
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study.

David M Pariser, Mark G Lebwohl, Janusz Jaworski

|Feb 11, 2025
Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.

Mark G Lebwohl, John Y Koo, Janusz Jaworski

|Jan 13, 2025
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study.

Gerd Burmester, Piotr Adrian Klimiuk, Jakub Trefler

Pageof 1

Frequent Collaborators

4 joint publications

SungHyun Kim

3 joint publications

YunJu Bae

1 joint publications

Gerd Burmester

1 joint publications

Piotr Adrian Klimiuk